Forecast & Rating2 analysts currently cover Organogenesis, of which 0 give a positive rating. The average price target is $2.00, about 43.9% upside from the current price of $1.39. Coverage is limited, so the data is for reference only. Data as of Aug 8, 2026; this does not constitute investment advice.
Aug 7, 2026Price forecast
$2.0043.88%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met35.5%
Stock price$1.39
Avg. target$8.5
High target$9
Low target$8
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.